Scholars Central

Conference abstractPublished 5 Sep 2011

Picomolar dichotomous activity of gnidimacrin against HIV-1

Authors: Chin-Ho Chen

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Highly active antiretroviral therapy (HAART) has off ered a promising approach for controlling HIV-1 replication in infected individuals. However, with HARRT, HIV- 1 is suppressed rather than eradicated due to persistence of HIV-1 in latent viral reservoirs. Th us, purging the virus from latent reservoirs is an important strategy toward eradicating HIV-1 infection. In this study, we discovered that the daphnanediterpenegnidimacrin, which was previously reported to have potent anti-cancer cell activity, activated HIV-1 replication and killed persistently-infected cells at picomolar concentrations. In addition to its potential to purge HIV-1 from latently infected cells, gnidimacrin potently inhibited a panel HIV-1 R5 virus infection of peripheral blood mononuclear cells (PBMCs) at an average concentration of lower than 10 pM. In contrast, gnidimacrin only partially inhibited HIV-1 X4 virus infection of PBMCs. Th e strong anti-HIV-1 R5 virus activity of gnidimacrin was correlated with its eff ect on down-regulation of the HIV-1 coreceptor CCR5. However, the anti-R5 virus activity was completely abrogated by a p56Lck inhibitor, which suggests that p56Lck play a key role in the potent anti-HIV-1 activity of gnidimacrin in PBMCs. Th ese results suggest that gnidimacrin could activate latent HIV-1, specifi cally kill HIV-1 persistently infected cells, and inhibit R5 viruses at picomolar concentrations.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Antivirals & Antiretrovirals
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Chin-Ho Chen”